Cancer Immunotherapy: At a Glance
The Foundation recognizes that the intersection of focused ultrasound therapy and cancer immunotherapy offers a highly promising opportunity for combination approaches to treat a variety of cancers. Through our Cancer Immunotherapy Program and in collaboration with our partners and the research community, we aim to explore and assess the full potential of focused ultrasound to turn this promise into reality.
Our Cancer Immunotherapy Program
In 2015, the Foundation established a dedicated Cancer Immunotherapy Program with a mission to explore the potential of focused ultrasound to impact the cancer immunotherapy field. Learn more >
The following videos and webinar recordings introduce the exciting fields of cancer immunotherapy and focused ultrasound.
Fireside Chat: Focused Ultrasound and Cancer Immunotherapy
In recognition of June as Cancer Immunotherapy Month, the Foundation’s Chief Scientific Officer, Jessica Foley, PhD, talked with Jill O’Donnell-Tormey, PhD, CEO of the Cancer Research Institute (CRI) and Theresa LaVallee, PhD, VP of Translational Medicine and Regulatory Affairs at the Parker Institute for Cancer Immunotherapy (PICI) about the lifesaving potential of cancer immunotherapy and how CRI and PICI are working together and also with the Foundation to advance exciting new research and bring new treatments to patients.
Cancer Immunotherapy Treatment and Research in a COVID-19 World
Dr. O’Donnell-Tormey and Dr. Foley discuss cancer immunotherapy and the ways that CRI and the Foundation are working together to advance exciting research, through a lens of the new COVID-19 environment.
Focused Ultrasound and Cancer Immunotherapy
Dr. Foley discusses focused ultrasound and its potential role in cancer immunotherapy.
An Introduction to Cancer Immunotherapy and Focused Ultrasound
Kelsie Timbie, PhD, Scientific Programs Manager and Veterinary Program Director, provides an introduction to how the fields of focused ultrasound and cancer immunotherapy intersect.
Help us Fund Research
Learn more about our $10 million campaign to support research on focused ultrasound’s role in immune-based treatment of cancer. Learn more >
Workshops & Symposia
Since 2015, the Foundation has organized and hosted five workshops on Cancer Immunotherapy and Focused Ultrasound, all in partnership with the Cancer Research Institute. The 2023 workshop was also held in partnership with the Parker Institute for Cancer Immunotherapy. Special sessions of our biennial symposia and other workshops have also covered cancer immunotherapy.
Focused Ultrasound and Cancer Immunotherapy Workshop (PDF) – July 18-19, 2023
Focused Ultrasound and Cancer Immunotherapy Workshop (PDF) – September 1-2, 2021
Focused Ultrasound for Glioblastoma Workshop (PDF) – May 19-20, 2021
Focused Ultrasound and Cancer Immunotherapy Workshop (PDF) – July 18-19, 2019
Focused Ultrasound and Pancreatic Cancer Workshop Summary (PDF) – February 28-March 1, 2019
Focused Ultrasound and Cancer Immunotherapy Workshop (PDF) – October 14, 2016
Focused Ultrasound and Cancer Immunotherapy Workshop (PDF) – February 11, 2015
Focused Ultrasound Foundation Symposium Summary 2022 (PDF)
Focused Ultrasound Foundation Symposium Summary 2020 (PDF)
Focused Ultrasound Foundation Symposium Summary 2018 (PDF)
Focused Ultrasound Foundation Symposium Summary 2016 (PDF)
Focused Ultrasound Foundation Symposium Summary 2014 (PDF)
FUS-IO Landscape Analysis
In April 2023, the Foundation published a landscape analysis to evaluate the rapidly growing field of focused ultrasound immuno-oncology (FUS-IO). The team compiled a library of FUS-IO references and assessed where the field stands with respect to six key questions. See the Landscape Analysis
By partnering with organizations who share our passion for results and collaboration, we expand our reach in the global community, deepen stakeholder investment, and leverage our donors’ contributions to advance our mission. Partnerships include but are not limited to fundraising, in-kind contributions, awareness, strategic input, and advancing critical research.
If you would like to know more about the Foundation’s Cancer Immunotherapy initiative, please contact Chief Scientific Officer, Jessica Foley, PhD.